Work

Leukocyte telomere length serves as the novel prognostic biomarker for the resectable NSCLC

Year: 2025

Type: article

Abstract: The relationship of Leukocyte telomere length (LTL) dynamic changes with resectable NSCLC progression remains unclear. This study aims to reveal its clinical utility for prognosis of the resectable NSCLC. LTL was measured in 76 resectable NSCLC patients and 80 healthy controls using peripheral blood samples. Pre-operation LTL (Pre-LTL) and post-operation LTL (Po-LTL) were analyzed in relation to TNM stage, metastasis, and survival outcomes. The prognostic value was evaluated by disease-free survival (DFS) and overall survival (OS). NSCLC patients had significantly shorter LTL compared to controls, with LTL inversely correlated to disease stage. Po-LTL increased significantly and was associated with better OS. Combining Po-LTL with TNM stage improved prognostic prediction for OS and DFS. LTL is a promising biomarker for predicting prognosis in resectable NSCLC. Po-LTL, as well as in combination with TNM stage, enhances predictive accuracy for OS and DFS.

Source: Scientific Reports

DOI: 10.1038/s41598-025-95569-8

Authors: Guanxuan Chen, Shiwen Wang, Xinkai Mo, Wanqi Zhu, Ruoyu Wang, Xingguo Song

Institutions: Affiliated Zhongshan Hospital of Dalian University, Harbin Medical University, Shandong Tumor Hospital, Shandong First Medical University

Language: English

Topic: Telomeres, Telomerase, and Senescence

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,690